Blood Banking & Blood Products

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Blood Components and Plasma Products
• Whole Blood & Cellular Components
• WBCs
• RBCs
• Platelets
• Plasma Fractions
• Fresh Frozen Plasma
• Albumin Fractions
• Factor VIII
• Factor IX and Factor IX Complex
• Fibrin/Thrombin
• Equipment, Blood Tests and Consumables
• Automated Analyzers for Blood Analysis
• Blood Tests
• Consumables

II. EXECUTIVE SUMMARY

1. Market Overview

• Healthcare Scares Propel the Market
• Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
• Worldwide Blood Banking and Blood Products Market at a Glance
• Current & Future Analysis
• Analysis by Geographic Region
• Analysis by Product Segment
• World Blood Components and Plasma Market Analysis in Units
• Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
• Red Blood Cells - A Key Blood Component and a Major Contributor
• Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)

2. Market Trends & Issues

• New Infections - A Continuous Threat...
• Safety and Availability: The Core Issues
• Decontamination: A Viable Process
• New Processes for Safer Blood Supply
• Innovative Procedures Help Blood Conservation
• Autologous Transfusion Strapping up for High Growth
• Enzyme Converted Cells Set to Rule the Industry
• Blood Unavailability: Substitutes to the Rescue
• Transfusions: Hospitals Making Way for Others
• Computer Identification Helps Patients
• SARS: A Case of Mistaken Identity?
• Pooling: Economical HIV Testing
• Private Cord Blood Banking: Flying High Despite Opposition
• Automation of Blood Banking - Nearing the Efficiency Frontier?
• Automated Instrumentation Taking the Front Seat
• Table 5: World Market for Blood Bank Technology (2004): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation(includes corresponding Graph/Chart)
• Table 6: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart)
• Plasma Market: Automation Making Inroads
• The RBC Market - Slow to Catch Up
• Automation of Testing - Yet to Mature
• Automation to Suffice Shortage Problems
• How Near to the Efficiency Frontier?

3. Product Overview

• Blood Banking and Blood Products Industry
• Blood Components and Plasma Products
• Equipment, Blood Tests and Consumables
• Automated Analyzers for Blood Analysis
• Blood Tests
• Consumables
• Blood - A Primer
• Ionic Structure
• Blood Components and their Applications
• Blood Constituents
• Plasma
• Table 7: World Recent Past, Current & Future Analysis for Plasma Products - Annual Sales Figures in US$ Million for Years 2003 through 2010 (includes corresponding Graph/Chart)
• Red Blood Cells (RBC)
• Blood Count
• Platelets
• White Blood Cells (WBC)
• Derivative Products of Blood or Plasma Fractions
• Plasma Protein and Fractionation
• The Need
• Fresh Frozen Plasma
• Other Plasma Fractions
• Albumin Fractions
• Albumin Usage Rising in Profile, Wastage Worries Run Deep
• Factor VIII
• Factor IX and Factor IX Complex
• Fibrin/Thrombin
• Consumption of Blood Based on Type of Surgery/ Accident (In Units)
• Table 8: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region/Country - USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
• Table 9: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Product Type - IVIG, Factor VIII, Albumin, Alpha-1, Fibrin, Factor IX, AT III, and Others (includes corresponding Graph/Chart)

4. Blood Collection Methods

• Banking the Natural Blood Resources
• Blood Banks
• Blood Banking
• Blood Transfusion
• Role of Blood Banks
• Blood Donor: The Epicenter of the Process
• Eligibility Criteria for the Donor
• The Basics of Blood Donation - Myths Exploded & Other Facts
• Collection Methods
• Blood Donation: The Process
• Types of Blood Donation
• Directed Blood Donations
• Autologous Blood Donation
• Alternative Usage of Patient' s Own Blood
• General Blood Donation
• Hemodilution
• Wound Drainage
• Cell Saver
• The Method
• Blood Salvaging
• Blood Collection Centers
• Blood Collection Management System
• A Historical Retrospective
• Blood Collection Centers
• Types of Blood Collection Centers
• Cord Blood Banks
• Profit Collection Centers
• Military Blood Banks
• Hospital Blood Banks
• Community Blood Banks
• Non-Profit Collection Centers
• Blood Processing
• Blood Typing
• Rh Blood Group System
• ABO Blood Group System
• Blood Types and their Compatibility
• Table 10: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)
• Blood Test
• Blood Culture
• The Costs

5. The Changing Landscape of Transfusion Technologies & Tests

• Blood Transfusion: A Backdrop
• Massive Transfusion
• Complications and Risks Due to Transfusion
• Circulatory Overload
• Graft Versus Host Disease (GVHD)
• Haemolytic Transfusion Reactions
• Iron Overload
• Bacterial Contamination
• Thrombophlebitis
• Allergic Reactions
• Air Embolism
• Hyperkalaemia
• Changing Role of Blood Banking Technology

6. Blood Transfusion: The Process,Tests/Technologies

• Cross Matching
• Blood Donor/Recipient Screening
• Blood Typing
• Leukoreduction
• Leukocyte Reduction Specification Standards/Filters
• Coombs Test

7. Alternatives to Blood Transfusion: A Real Threat to the Industry

• Bloodless Surgery
• Therapeutic Apheresis
• Plasmapheresis
• Plateletpheresis
• Leukapheresis
• Volume Expanders
• Colloids
• Albumin
• Dextrans
• Hydroxyethyl Starch
• Crystalloids
• Blood Growth Factor Therapies - Newer Alternatives to Transfusion

8. Blood Substitutes

• Blood Substitutes Under Development by Manufacturers
• Synthetic Blood Manufacturers/Developers
• Alliance Pharmaceuticals Corp. (USA)
• Biopure Corporation (USA)
• Enzon Pharmaceuticals (USA)
• Hemosol Inc. (Canada)
• Northfield Laboratories Inc. (USA)
• Synthetic Blood International, Inc. (USA)

9. Product Introductions/Innovations

• Pall Unveils Acrodose(tm) PLus System
• Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market
• Dade Behring Launches the Quadriga BeFree System
• Swedish Inventors Develop New Processing System
• Canada Invents New Method for Monitoring Blood and Blood Products
• Terumo Launches Improvised Bags For Safe Blood Collection
• Haemonetics Launches Cymbal Automated Blood Collection System
• Illinois Inventors Introduces New Systems to Prepare Blood Products
• Abbott Unveils Two New Products for Blood Banks
• Cell Robotics Introduces New Lasette P 200
• Beckman' s COULTER(r) LH 750 Hematology Analyzers Hit the Market
• Haemonetics Unveils MCS(r)+ - Improved Red Cell Collection Technology
• Baxter Launches ALYX Component Collection System
• Grifols' DG Gel(r) Revolutionizes Column Agglutination
• BioMerieux Introduces DAVINCI(r)...
• Pall Develops Novel Blood Filtration Membrane

10. Products in Pipeline & Technology Update

• From Clinical Trials to Clinics
• Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets
• Haemonetics Wins FDA Approval for the ACP 215 System
• Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance
• Pall' s eBDS Receives Green Signal from FDA
• CardioPAT(tm) Surgical Blood Salvage System
• PCS(r) 2 - Set to Enhance Plasma Quality
• Dade Behring' s D-Dimer Assay Strapping up for Roll Out

11. Recent Industry Activity

• ZymoGenetics Obtains FDA Approval for Marketing Recothrom
• CellaVision Enters into a Two-Year Manufacturing Agreement with Kitron AB
• PerkinElmer Completes ViaCell Acquisition
• Texas Cord Blood Bank Expands Cord Blood Collection Network
• Inverness Medical Acquires HemoSense
• Haemonetics Acquires Haemoscope' Hemostasis Analyzer Business Unit
• NxStage Medical Completes Medisystems Acquisition
• CordLife Establishes Cord Blood Bank in Indonesia
• Xinjiang Deyuan Begins Construction of a New Blood Product Plant
• Cord Blood America Acquires Curesource
• Grifols and Cerus Join Hands to Commercialize Cerus' Intercept Blood System
• SFDA Revokes Drug Approval and Production Permit of Guangdong Bioyee
• Immucor Obtains Clearance from FDA for Marketing Galileo Echo
• Cryobanks to Set Up a Cord Blood Bank in Thailand
• Grifols to Manage Four New Plasma Collection Centers in US
• Hualan Biological Acquires Chongqing Yituo
• CyGenics to Focus on Cord Blood Banking
• Cord Blood America Acquires CorCell
• Stemcyte to Establish Cord Blood Bank in India
• Baxter Divests Transfusion Therapies Business
• Cerus Obtains Approval for Intercept Blood System in Germany
• Cangene Obtains Health Canada Approval for Anti-Hepatitis B Blood Product
• Cord Blood America Inks Marketing Agreement with MSBCBS
• BCCL Acquires Stake in Life Cell
• SunTech Medical Group Acquires Empirical Technologies
• Cord Blood America Acquires Cryobank
• Kalbe Acquires Stake in CyGenics' s Subsidiary CordLife Indonesia
• Cryobanks International Signs Letters of Intent with MedStem Services
• Cryobanks International Opens Cord Blood Stem Cell Bank
• DomaniCell Initiates Family Cord Blood Banking Program in Hospitals
• Cryobanks International Grants License for Cord Blood Processing System
• Community Blood Center Bags Contract
• Wilkes Medical Center Grants License for SafeTrace Tx
• Biosite Collaborates with HUG Research Hospital
• Pliva Terminates Agreement with Mayne
• Mississippi Blood Services Secures Contract
• APL Partners with Omscan
• DomaniCell Receives Stem Cell Banking License
• ThermoGenesis Enters into an Agreement with Cord Blood Registry
• ZLB Enters into Plasma Deal with BCA
• ViaCell and Pall Secure FDA Approval for ViaCord(r) Collection Kit
• Pall Secures Contract from NBS to Supply ' Leukotrap' Filtration System
• Biotest and Sanquin to Form Joint Venture for Plasma Production
• Consorta Signs Partnership Agreement with GSABC
• Haemonetics Signs Supply Agreement with Canadian Blood Services
• Haemonetics Extends the Agreement with American Red Cross
• Novation and Abbott Enter into a Technology Agreement
• Olympus Redefines the Agreement with Biotest
• Cerus to Receive Marketing Rights over Baxter' s INTERCEPT Blood System
• CyGenics to Establish a New Cord Blood Banking Company
• UKCBB to Establish a Modern Laboratory in UMIC' s New CTF
• St. John' s Medical Center Procures Wyndgate' s SafeTrace Tx
• Florida`s Blood Centers Acquires South Florida Blood Banks
• BioStem Takes Over Cryobanks International
• FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public Donation Option
• Pall Signs Sale Agreement with Green Cross for Blood Filters
• TCBB Starts Collecting Donations for Cord Blood
• Pall Received FDA Clearance to Market New Pall Acrodose(tm) PL System
• CordLife Singapore Receives AABB Accreditation
• ITL and ARC Enter into an Agreement for Blood Bank Equipment
• NBA and UKT Merge to Form NHSBT
• BioMerieux and ExonHit Extend Collaboration to Develop Blood Diagnostics
• Wyndgate Signs Agreement with Cameron Hospital
• Daxor' s Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers
• Baxter and American Red Cross Enter Into Agreement
• CSL Signs Agreement with National Blood Authority
• Chiron Finds a South African Partner for Procleix(r) Tigris(r)
• ThermoGenesis and BHHTI Jointly Market CryoSeal FS
• Baxter and Cerus Enter into a Marketing Agreement
• Haemonetics Signs Technology Alliance with ZLB Plasma Services
• BioTime Collaborates with Summit Pharmaceuticals International Corp.
• SurgiLance Bags a Contract from America' s Blood Centers
• Florida' s Blood Centers Acquire Lake Park-based South Florida Blood Banks
• Global Med Technologies' Division Signs Agreement with Hospital Partners of America
• Radiometer America and Consorta Extend Blood-Gas Products Deal
• Baxter' s ALYX System Wins Medical Design Excellence Award
• Terumo Corp. Ups Stake in Blood Bag Venture
• Vita 34 International AG Takes over the Holdings of Corcell and Vita 34
• CSL Acquires Aventis Behring
• Medsurge Medical Products Corp. Buys Cryo Genomics
• Haemonetics' Acquisition of Harvest Technologies Expands Surgical Blood Salvage Portfolio
• Chiron Buys Prion Solutions
• Celmed & Gambro Tie up for GvHD Prevention System
• Chiron Grants NAT Licenses to LabCorp and German Red Cross
• Sekisui Chemical Ventures into Chinese Blood Collection Market
• Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer
• PRDT, ARC & Maco Pharma in a Strategic Alliance
• Pall' s Enhanced Bacterial Detection System to be Marketed by Kawasumi
• Baxter and Cerus Rope in Bioone Corp for Marketing Intercept
• Chiron Partners with ZymeQuest
• Pall Corporation Signs Agreement with Haemonetics Corporation
• Haemonetics Corporation & Hemosystem SA in a Marketing Alliance
• Chiron' s Armor Strengthened with Infectio' s Rapid Bacterial Detection Licenses
• Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver(r) 5
• Haemonetics Obtains Marketing Licenses for Crit Scan(r)
• Lifebank Receives AABB Accreditation
• Bayer Divests Plasma Products Business to NPS
• ITL Receives FDA Clearance to Market SSK
• Chronix Biomedical Files Patent Approval for a New Diagnostic Test
• ViaCell' s Selective Amplification(tm) Program Boosts Cord Blood Banks' Productivity
• CordLife Opens Second Cord Blood Banking Facility Singapore
• PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation Technologies
• Novation Bags Big Ticket Deals for Blood Products

12. Focus on Select Global Players

• Leading Blood Banks
• America' s Blood Centers (USA)
• AABB (USA)
• American Red Cross (USA)
• CorCell Inc. (USA)
• Japan Red Cross (Japan)
• LifeBank Cryogenics (Canada)
• National Blood Foundation (USA)
• New England Cord Blood Bank, Inc. (USA)
• New York Blood Center (USA)
• The Cord Blood Registry (USA)
• VITA 34 AG (Germany)
• Leading Players in Blood Bank Technology & Supplies
• Beckman Coulter Inc (USA)
• Becton Dickinson (USA)
• Bio Products Laboratory (UK)
• Chiron Corporation (USA)
• CSL Behring (USA)
• Daxor Corporation (USA)
• Fresenius Group (Germany)
• Gambro BCT (US)
• Gen-Probe Incorporated (USA)
• Grifols (Spain)
• Haemonetics (USA)
• Hemagen Diagnostics Inc. (USA)
• Immucor Inc. (USA)
• Kawasumi Laboratories, Inc. (Japan)
• Olympus America, Inc. (USA)
• PharmaStem Therapeutics, Inc. (USA)
• Terumo Corporation (Japan)
• ThermoGenesis Corp. (USA)
• ZymeQuest, Inc. (USA)

13. Global Market Perspective

• Table 11: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 12: World Long-term Projections for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 13: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 14: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 15: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 16: World Long-term Projections for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 17: World Historic Review for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 18: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 19: World Long-term Projections for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 20: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 21: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 22: World 15-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1998, 2008 & 2012
• Table 23: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 24: World Long-term Projections for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 25: World Historic Review for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 26: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 27: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 28: World Long-term Projections for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 29: World Historic Review for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 30: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 31: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 32: World Long-term Projections for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 33: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 34: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • Market Trends
  • US Blood Collection & Supply Profile
  • Blood Group Distribution
  • Table 35: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)
  • Table 36: Percentage Break up of Rh Blood Types in the US by Racial Group
  • Blood Donated and Transfused Every Year
  • Males Form the Major Chunk of Donors
  • Cost of Blood
  • SARS Scares: Blood Banks Feel the Heat
  • Whole Human Blood: Export-Import Scenario in the Recent Past
  • Table 37: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Exports by Country - France, Canada, UK, Germany, Japan, Taiwan, Korea, Belgium, Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart)
  • Table 38: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Value Exports by Country - France, UK, Germany, Japan, Canada, Belgium, Korea, Peru, Taiwan, Netherlands, Italy, and Others (includes corresponding Graph/Chart)
  • Table 39: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Consumption of Volume Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
  • Table 40: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Consumption of Value Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
  • US Blood Components and Plasma Market Analysis in Units
  • Table 41: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 42: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
  • Product Launches/Developments
  • Strategic Corporate Developments
  • Key Players
  • Blood Banks
  • America' s Blood Centers
  • AABB
  • American Red Cross
  • Blood Bank of Alaska
  • California Cryobank
  • Community Blood Bank
  • CorCell Inc.
  • National Blood Foundation
  • New England Cord Blood Bank, Inc.
  • New York Blood Center
  • Oklahoma Blood Institute
  • The Cord Blood Registry
  • Blood Bank Technology Developers and Consumables Suppliers
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Chiron Corporation
  • CSL Behring (USA)
  • Daxor Corporation
  • Gen-Probe Incorporated
  • Gambro BCT
  • Haemonetics
  • Hemagen Diagnostics Inc.
  • Immucor Inc.
  • Olympus America, Inc.
  • PharmaStem Therapeutics, Inc.
  • ThermoGenesis Corp.
  • ViaCell, Inc.
  • ZymeQuest, Inc.
• B. Market Analytics
  • Table 43: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 44: US Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 45: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 46: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Current and Future Analysis
  • The ' CSA-Z 902-04' - A Comprehensive Voluntary Blood Safety Standard
  • LifeBank Cryogenics - The Only AABB Accredited Cord blood Stem Cell Bank
  • Product Launches/Developments
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 47: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 48: Canadian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 49: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 50: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Current and Future Analysis
  • Growing Market for Fresh Frozen Plasma
  • Strategic Corporate Developments
  • Key Players
  • Japan Red Cross
  • Kawasumi Laboratories, Inc.
  • Terumo Corporation
• B. Market Analytics
  • Table 51: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 52: Japanese Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 53: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 54: Japanese 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

• A. Market Analysis
  • Current & Future Analysis
  • Analysis by Geographic Region
  • European Blood Banking and Blood Products Market at a Glance (All figures are 2008 estimates & CAGR is for the period 2001-2010)
  • Analysis by Product Segment
  • Market Trends and Issues
  • Legislations on Payment for Donation Restrict Donors
  • Government' s Check on Healthcare Costs Pressurizes BCT Manufacturers
  • Purchasing System Witnesses Modifications
  • EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products
  • A Snapshot of Health Care Systems Across Select EU Countries
  • France
  • Germany
  • Italy
  • The UK
  • Spain
  • Product Launches/Developments
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 55: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 56: European Long-term Projections for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 57: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 58: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 59: European Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 60: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 61: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 62: European 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 63: Leading Players in the French Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart)
• B. Market Analytics
  • Table 64: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 65: French Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 66: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 67: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 68: Leading Players in the German Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart)
  • Key Players
  • Fresenius Group
  • VITA 34 AG
• B. Market Analytics
  • Table 69: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 70: German Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 71: German Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 72: German 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

• Market Analysis
• Current and Future Analysis
• Table 73: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 74: Italian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 75: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 76: Italian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 77: Leading Players in the UK Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown of Revenues for Bio Products Laboratory, Baxter, Grifols, and Others (includes corresponding Graph/Chart)
  • Key Player
  • Bio Products Laboratory
  • Surgical Innovation Group Plc
• B. Market Analytics
  • Table 78: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding raph/Chart)
  • Table 79: UK Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 80: UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 81: UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Spain

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 82: Leading Players in the Spanish Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Baxter, Grifols, ZLB Behring, and Others (includes corresponding Graph/Chart)
  • Strategic Corporate Development
  • Key Player
  • Grifols
• B. Market Analytics
  • Table 83: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding raph/Chart)
  • Table 84: Spanish Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 85: Spanish Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 86: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4f. Russia

• Market Analysis
• Current and Future Analysis
• Table 87: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 88: Russian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 89: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 90: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4g. Rest of Europe

• A. Market Analysis
  • Current and Future Analysis
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 91: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 92: Rest of Europe Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 93: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 94: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Current and Future Analysis
  • ASEAN - Striding Towards Standardization of Blood Supply
  • China - A Key Market
  • Government Wakes Up to Realities
  • Table 95: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
  • Table 96: Chinese Market for Blood Banking & Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female
  • Table 97: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart)
  • Strategic Corporate Developments
  • Key Players
  • Indian Red Cross Society (India)
• B. Market Analytics
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 99: Asia-Pacific Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 100: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 101: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

6. Latin America

• Market Analysis
• Current and Future Analysis
• Table 102: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 103: Latin American Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 104: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 105: Latin American 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

7. Rest of World

• Market Analysis
• Current and Future Analysis
• Table 106: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 107: Rest of World Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 108: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 109: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)